Letters to the Editor

Amphiregulin as monitoring biomarker for life-threatening acute graft-versushost disease: secondary analysis of two prospective clinical trials

University of Minnesota, Adult Blood and Marrow Transplant and Cell Therapy Program, Minneapolis, MN
University of Minnesota, Adult Blood and Marrow Transplant and Cell Therapy Program, Minneapolis, MN
University of Minnesota, Adult Blood and Marrow Transplant and Cell Therapy Program, Minneapolis, MN; Fred Hutchinson Cancer Center
University of Minnesota, Adult Blood and Marrow Transplant and Cell Therapy Program, Minneapolis, MN
Biostatistics Core, Masonic Cancer Center, University of Minnesota, Minneapolis, MN
Incyte Corporation, Wilmington, DE
University of Minnesota, Pediatric Blood and Marrow Transplant and Cell Therapy Program, Minneapolis, MN
University of Minnesota, Adult Blood and Marrow Transplant and Cell Therapy Program, Minneapolis, MN
University of Minnesota, Pediatric Blood and Marrow Transplant and Cell Therapy Program, Minneapolis, MN
Incyte Corporation, Wilmington, DE
Haematologica Early view Sep 14, 2023 https://doi.org/10.3324/haematol.2023.283215